Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis
Winyard, Paul G.
Arthritis and Rheumatism
Reason for embargo
Type II collagen (CII) posttranslationally modified by reactive oxygen species (ROS-CII) that are present in the inflamed joint is an autoantigen in rheumatoid arthritis (RA). The aim of this study was to investigate the potential use of anti-ROS-CII autoantibodies as a biomarker of RA.
The definitive version is available at www3.interscience.wiley.com
Arthritis and Rheumatism, 2013, Vol. 65, Issue 7, pp. 1702 - 1712